Plasma homocysteine and menopausal status

European Journal of Clinical Investigation

Volumn 25, Issue 11, 1995, Pages 801-805

  WOUTERS, M G A J ^a   MOORREES, M Th E C ^a   MOOREN, M J VAN DER ^a   BLOM, H J ^b   BOERS, G H J ^b   SCHELLEKENS, L A ^a   THOMAS, C M G ^a   ESKES, T K A B ^a  

^a Departments of Obstetrics and Gynaecology ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Homocysteine; menopause; oestradiol; vitamins

Indexed keywords

ESTRADIOL; HOMOCYSTEINE; METHIONINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MENOPAUSE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ESTRADIOL; FEMALE; HOMOCYSTEINE; HUMANS; METHIONINE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; VITAMINS;

EID: 0028869071     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1995.tb01687.x     Document Type: Article

References (29)

1. Disorders of transsulfuration
2. Total homocysteine in plasma or serum: methods and clinical applications
3. Plasma homocysteine and cardiovascular disease
4. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
5. Hyperhomocystei‐nemia: a risk factor in women with unexplained recurrent early pregnancy loss
6. Maternal hyperhomocysteinemia: a risk factor for neural‐tube defects
7. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae [letter]
8. Cysteine‐homocysteine mixed disul‐phide: differing plasma concentrations in normal men and women
9. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years
10. Folic acid responsive postmenopausal homocysteinemia
11. Protein‐bound homocyst(e)ine: a possible risk factor for coronary artery disease
12. Plasma sulfhydryl‐containing amino acids in patients with cerebral infarction and in hypertensive subjects
13. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
14. Homocyst(e)inemia in daily practice: levels in coronary artery disease
15. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects
16. Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjects
17. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
18. Homocysteine and other thiols determined in plasma and urine: automation and sample stability
19. Assessment of uncon‐jugated oestradiol and progesterone serum levels throughout pregnancy in normal women and in women with hyperprolacti‐naemia who conceived after Bromocriptine treatment
20. Multivitamin supplementation in oral contraceptive users
21. Effects of sub‐50 oral contraceptives on homocysteine metabolism: a preliminary study
22. Total plasma homocysteine: influence of some physiological variables
23. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women
24. Decreased serum homocysteine in pregnancy
25. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women
26. Plasma homocysteine in women on oral oestrogen‐containing contraceptives and in men with oestrogen‐treated prostatic carcinoma
27. Impaired homocysteine metabolism in early‐onset cerebral and peripheral occlusive arterial disease—effects of pyridoxine and folic acid treatment
28. Plasma homo‐cyst(e)ine, folate, and vitamin B12 concentrations and risk for early‐onset coronary artery disease
29. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population